Turn Therapeutics (TTRX) Leases (2024 - 2026)

Name: Turn Therapeutics (TTRX) Leases (2024 - 2026) | Business Quant
Creator: Business Quant

Turn Therapeutics' quarterly Leases came in at $67573.0 in Q1 2026, down 14.05% quarter-over-quarter from $78620.0 in Q4 2025.

Turn Therapeutics has reported Leases for 3 years, with the latest figure at $67573.0 in Q1 2026.

For the quarter ending Q1 2026, Leases changed N/A year-over-year to $67573.0; the trailing twelve-month figure through Mar 2026 stood at $67573.0 (changed N/A YoY), and the FY2025 full-year result was $78620.0, down 34.73% from the prior year.
Leases for Q1 2026 stood at $67573.0, down from $78620.0 in the prior quarter.
The five-year high for Leases was $120452.0 in Q4 2024, with the low at $67573.0 in Q1 2026.
Average Leases over 3 years is $89017.0, with a median of $84021.5 recorded in 2025.
Peak annual rise in Leases reached 34.73% in 2025, while the deepest fall reached 34.73% in 2025.
Tracing TTRX's Leases over 3 years: stood at $120452.0 in 2024, then plunged by 34.73% to $78620.0 in 2025, then declined by 14.05% to $67573.0 in 2026.
The last three Leases figures came in at $67573.0 (Q1 2026), $78620.0 (Q4 2025), and $89423.0 (Q3 2025), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Leases (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	83,048.00
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	61,822.50
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	285.20 Mn
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	1.69 Bn
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	-
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	189.30 Mn
10	Turn Therapeutics	188.06 Mn	188.06 Mn	-	67,573.00

Download Data 🔒